EN  |  FR

Private Corner launches a healthcare feeder with Mérieux Equity Partners for its Mérieux Innovation 2 fund

Paris, 20 November 2024 - Private Corner, a French digital asset management company specialising in unlisted assets, is launching PC Feeder Mérieux Innovation 2, a private equity feeder fund for the second vintage of Mérieux Equity Partners' healthcare innovation strategy. This is an opportunity for private clients, through their financial advisers, to invest in a vehicle that aims to support innovation in the European healthcare sector, while being eligible for the 150-0 B ter reinvestment scheme (contribution-cession).

If you have any questions about this feeder fund or the other unlisted funds available, please do not hesitate to ask our experts for advice:

Contact our Private Equity expert

Mérieux Equity Partners: a major player in healthcare private equity

Mérieux Equity Partners is one of Europe's most recognised and active players in healthcare private equity. This second vintage is in line with Mérieux Equity Partners‘ mission to accelerate and broaden access to products and services with a high impact on patients’ lives (such as early diagnosis, robotisation of surgical procedures and miniaturisation of medical devices).

The Mérieux Innovation 2 master investment fund, recently awarded the Tibi label, will support around 15 innovative European companies focusing on cutting-edge technological advances or scientific breakthroughs. These companies will benefit from the financial and operational support of Mérieux Innovation 2, enabling them to develop their products and services until the handover to an industrial player capable of accelerating the process of bringing products and services to market.

Through the feeder fund, PC Feeder Mérieux Innovation 2, managed by Private Corner, private investors, via their financial advisers, will be able to invest from €100,000, called up over a period of 4 to 5 years. This feeder private equity fund aggregates subscriptions from private investors (individuals and legal entities) in a dedicated vehicle, structured as an FPCI (Fonds Professionnel de Capital-Investissement), which will invest directly in the underlying target fund Mérieux Innovation 2. It is categorised as an Article 8 SFDR and is eligible for the tax deferral provided for in Article 150-0 B ter of the French General Tax Code (contribution-cession scheme) as well as for the preferential capital gains regime.

Discover our complete range of unlisted funds

Investing in Europe's healthcare sector: a dynamic and buoyant market

This private equity fund targets companies at different stages of maturity in order to diversify and reduce risk, and which are developing technological platforms so as not to be dependent on a single product or application. The strategy deployed focuses on 4 main verticals with a strong AI and technology component: diagnostic and therapeutic platforms, medical devices, services for the pharmaceutical industry and tools for life sciences. ‘The European M&A market in the healthcare sector is dynamic, offering investors attractive opportunities through strategic exits. European Innovation investments in the healthcare sector have shown a net return of over 20% over 10 years, outperforming European benchmarks. Backed by an entrepreneurial family through the Mérieux Group with over a century of experience in healthcare and more than 50 completed transactions, Mérieux Equity Partners focuses on the healthcare sector, giving it a deep understanding of the challenges and opportunities in the field. This is why we have chosen to join forces with Mérieux Equity Partners for the second time, to enable our distribution network to offer their clients the opportunity to diversify their investments in a promising sector,’ says Estelle Dolla, President and co-founder of Private Corner.

‘Our mission is to accelerate patient access to products and services that have a transformative impact on their health. To achieve this, we support innovative European companies with a strong scientific or technological component. After a successful initial collaboration on our buyout fund Mérieux Participations 4, we are delighted to be continuing our partnership with Private Corner to offer private investors the opportunity to participate from €100,000’, says Valérie Calenda, Partner in charge of Innovation at Mérieux Equity Partners.

The feeder fund will be on the market until the end of 2025.


About Private Corner

Private Corner is a company approved as a portfolio management company on 05/11/2020 by the AMF under number GP-20000038. It provides wealth and asset management specialists with a secure digital investment platform 100% dedicated to unlisted assets. Private Corner provides access to a selection of leading investment funds, generally reserved for institutional investors or large families. Investing in alternative investment funds (AIFs) entails risks, particularly of loss of capital and liquidity risks.

About Mérieux Equity Partners

Mérieux Equity Partners (‘MxEP’) is an AMF-accredited investment management company specialising in the healthcare sector. With over €1.5 billion in assets under management, MxEP's portfolio covers the most promising mature and innovative healthcare products and services across Europe. Based in Lyon and Paris, the MxEP team is made up of healthcare specialists and investment professionals who support European companies with strong growth and transformation potential, benefiting from Mérieux's industrial roots and international vision. Through our two strategies, Buyout (Mérieux Participations funds) and Venture (Mérieux Innovation funds), MxEP identifies the most innovative healthcare companies and provides capital, network and expertise to entrepreneurs and management teams to accelerate their growth and improve patient outcomes.

For more information, please visit www.merieux-partners.com

Interested in investing in this feeder fund or other private equity funds? Contact our private equity experts!

Contact a Private Corner expert

Let's work together